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PCardiac Magnetic Resonance
nfarct Morphology Identifies Patients With
ubstrate for Sustained Ventricular Tachycardia
avid Bello, MD, David S. Fieno, PHD, Raymond J. Kim, MD, F. Scott Pereles, MD,
od Passman, MD, FACC, Gina Song, BA, Alan H. Kadish, MD, FACC,
effrey J. Goldberger, MD, FACC
hicago, Illinois
OBJECTIVES We sought to evaluate whether infarct size characterization by cardiac magnetic resonance
imaging (MRI) is a better predictor of inducible ventricular tachycardia (VT) than left
ventricular ejection fraction (LVEF).
BACKGROUND Inducibility of VT at electrophysiologic study (EPS) and low LVEF can identify patients with
a substrate for VT. Magnetic resonance imaging has been shown to identify, with high
precision, areas of myocardial infarction and may therefore be a better tool to evaluate for a
substrate for VT.
METHODS We studied 48 patients with known coronary artery disease who were referred for EPS using
cine and gadolinium-enhanced MRI. Wall motion and infarct characteristics were deter-
mined blindly and compared among patients with no inducible ventricular arrhythmias (n 
21), those with inducible monomorphic VT (MVT, n  18), and those with either inducible
polymorphic VT or ventricular fibrillation (n  9).
RESULTS Patients with MVT had larger infarcts than patients who did not have inducible arrhythmias
(mass: 49  5 g [SE] vs. 28  5 g, p  0.005; surface area: 172  15 cm2 vs. 93  14 cm2,
p  0.0005). Patients with polymorphic VT/fibrillation had intermediate values (mass: 36 
7 g; surface area: 115  22 cm2). Ejection fraction was inversely related to infarct mass and
surface area, with R2 values ranging from 0.21 to 0.27. Logistic regression and receiver-
operating characteristic analysis demonstrated that infarct mass and surface area were better
predictors of inducibility of MVT than LVEF.
CONCLUSIONS Infarct surface area and mass, as measured by cardiac MRI, are better identifiers of patients
who have a substrate for MVT than LVEF. Further evaluation of infarct size characterization
by cardiac MRI as a predictor of sudden cardiac death is warranted. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.12.0572005;45:1104–8) © 2005 by the American College of Cardiology Foundation
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Eudden cardiac death in patients with coronary artery
isease (CAD) is predominantly caused by ventricular
achycardia (VT)/ventricular fibrillation (VF). Patients with
low left ventricular ejection fraction (LVEF) and inducible
T during electrophysiologic study (EPS) are at risk of sudden
eath and may benefit from implantable cardioverter-
efibrillator (ICD) therapy (1–3). Low LVEF and VT
nducibility identify a substrate for VT. Ventricular tachy-
ardia occurs more commonly in the setting of larger
nfarcts (4–7), and LVEF is inversely related to infarct size
8–11). Furthermore, EPS directly establishes the presence
f a substrate by the actual induction of VT. To date, there
s only indirect information relating infarct size or morphol-
gy to the presence of a substrate for VT in humans.
ontrast-enhanced magnetic resonance imaging (ceMRI)
ith a gadolinium-based contrast agent has been shown to
dentify, with high precision, areas of myocardial infarction
n both animals (12,13) and humans (14–16). We hypoth-
From the Department of Medicine, Divisions of Cardiology and Radiology,
orthwestern University, Feinberg School of Medicine, Chicago, Illinois. This study
as supported in part by the ACC/MERK award (to Dr. Bello). Dr. Bello was Merck
ellow of the American College of Cardiology from 2001 to 2002.f
Manuscript received July 2, 2004; revised manuscript received December 13, 2004,
ccepted December 14, 2004.sized that infarct size and/or morphology detected by ceMRI
s a better predictor of EPS inducibility of VT than LVEF.
ETHODS
orty-eight patients with CAD referred for EPS to assess
or inducibility of VT were enrolled in accordance with the
olicies of the Institutional Review Board. Patients under-
ent MRI scanning within 32  6 days of EPS. Patients
ere placed supine in a 1.5-T Magnetom Sonata scanner
Siemens, Medical Solutions, Malvern, Pennsylvania); fi-
eroptic electrocardiographic (ECG) leads were placed for
canner gating and a phased-array receiver coil was placed
n the chest for imaging. All images were acquired using
0- to 15-s breath-holds. Short-axis slices were acquired
rom the base to apex, making sure to include the entire left
entricle using methods previously described (16,17). A
adolinium-based contrast agent (0.1 to 0.2 mmol/kg,
agnevist, Berlex Pharmaceuticals, Wayne, New Jersey)
as administered intravenously, and images were obtained
s described previously (15).
Image data sets were scored by reviewers blinded to the
PS results. All images were reviewed off-line and arranged
rom base to apex using National Institutes of Health
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neurysm and segmental wall motion abnormalities was
oted. Endocardial and epicardial borders of the myocar-
ium were manually planimetered on the short-axis cine
mages for each patient. Volumes were derived by summa-
ion of the pixel areas, followed by multiplication of in-
lane resolution and the effective slice thickness. The LVEF
as computed as:
end-diastolic volume end-systolic volume
end-diastolic volume
Left ventricular mass was determined by subtracting
ndocardial volume from epicardial volume at end diastole
nd multiplying by a density of 1.05 g/ml (18). Infarct
orphology was evaluated using the ceMRI images. The
resence of myocardial infarction, its location, and the
egree of transmurality were agreed upon by two observers.
o measure infarct mass and surface area, the infarct region
as outlined according to whether the image intensity was
2 SD that of a remote region in the same slice. From the
ontours, a pixel value was computed for the area and surface
f each individual infarct territory. Based on the pixel values,
he image resolution and slice thickness, and an assumed
ensity of 1.05 g/ml, the pixel values were converted into actual
ardiac masses and surface areas. Infarct surface area and infarct
ass (absolute and percent left ventricular mass) were calcu-
ated. The surface area to volume ratio was calculated as an
ndex of complex infarct morphology.
Electrophysiologic study was performed using standard
echniques. Programmed ventricular stimulation was per-
ormed using up to three extrastimuli at two right ventric-
lar sites during two drive-cycle lengths. Study end points
ere either induction of sustained VT or completion of the
tudy protocol. Results were classified as: 1) inducible,
ustained monomorphic VT (MVT); 2) inducible polymor-
hic VT (PVT, 15 complexes), VF, or ventricular flutter;
r 3) no inducible VT/VF. Induction of MVT is highly
eproducible (19,20) and typically identifies the presence of
fixed substrate for reentry (20). In contrast, induction of
VT/VF may be nonspecific due to aggressive stimulation;
hese arrhythmias can be induced in patients with normal
earts and normal QT intervals (21–24). Yet, PVT/VF is
Abbreviations and Acronyms
CAD  coronary artery disease
ceMRI  contrast-enhanced magnetic resonance imaging
EPS  electrophysiologic study
LVEF  left ventricular ejection fraction
MRI  magnetic resonance imaging
MVT  monomorphic ventricular tachycardia
PVT  polymorphic ventricular tachycardia
ROC  receiver-operating characteristic
VF  ventricular fibrillation
VT  ventricular tachycardiaommonly induced in survivors of cardiac arrest (22,25). shus, in order to evaluate the utility of infarct characteristics
dentified by MRI to identify patients with a substrate for
T, the main analysis of this report focuses on patients with
nducible MVT versus those without inducible VT/VF.
Data are presented as the mean value  SE. Linear and
ogistic regression analysis, analysis of variance, contingency
nalysis, and the t test or Fisher exact test were used as
ppropriate. The receiver-operating characteristic (ROC)
urves were generated and compared for prediction of induc-
bility according to the method described by Metz (26). A p
alue 0.05 was regarded as statistically significant.
ESULTS
linical and MRI characteristics of the study population are
ummarized in Table 1. Sustained MVT was induced with
ne (n  1), two (n  10), or three (n  7) extrastimuli in
8 patients (cycle length 270  11 ms), whereas PVT/VF
as induced with three extrastimuli in all nine subjects. The
hree patients without evidence of hyperenhancement on
eMRI had LVEFs of 44% to 62%; all had CAD by
ngiography and had EPS for near syncope or risk stratifi-
ation for nonsustained VT. Infarct mass, absolute (49 
g vs. 28  5 g, p  0.005) and as percent left ventricular
ass (26  3% vs. 14  3%, p  0.004), and surface area
172  15 cm2 vs. 93  14 cm2, p  0.0005) were larger in
atients with inducible MVT than in those without induc-
ble VT/VF. The LVEF was lower in patients with induc-
ble MVT versus those without inducible ventricular ar-
hythmias, but this difference was not statistically significant
28  2% vs. 35  3%, p  0.08). In general, values for the
RI findings in patients with PVT/VF were intermediate
etween those noted in patients with inducible MVT and
atients without inducible ventricular arrhythmias; there
ere no significant differences between the patients with
nducible PVT/VF and those without VT/VF. Significant
ifferences between the patients with PVT/VF and the
atients with inducible MVT were noted only for infarct
urface area (p  0.04) and the number of disconnected
reas of infarction (p  0.02). When patients taking
miodarone were excluded from the analysis, the qualitative
ndings remained unchanged.
Figure 1 shows the relationship between infarct size
arameters and LVEF. Although infarct size correlates
egatively with LVEF, the strength of the correlation is
eak, with R2 values from 0.21 to 0.27. Of note, the
istribution of patients with inducible MVT tends to cluster
bove the regression line, whereas those without inducible
T/VF tend to cluster below the line, consistent with the
otion that LVEF may “overstate” infarct size in patients
ithout inducible MVT, and vice versa.
Logistic regression revealed that infarct surface area and
nfarct mass were significant predictors of inducible VT,
hereas LVEF was not. The logistic regression models re-
ealed chi-square and p values of 6.6 and 0.01 for infarct
urface area, 0.3 and0.6 for LVEF, 5.2 and0.02 for infarct
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.5 and0.03 for infarct mass (absolute), and 0.7 and0.4 for
VEF, respectively. Figure 2 demonstrates ROC curves for
VEF and infarct surface area as predictors of inducible VT.
he ROC curve for infarct surface area is shifted up and to the
eft relative to the curve for LVEF, indicating it is a better
redictor of VT inducibility than LVEF (p  0.05). Table 2
emonstrates the sensitivity and specificity for various cut-off
alues of LVEF, infarct surface area, and infarct mass, as well
able 1. Characteristics of the Study Population
Characteristic
p Value
(Difference Among Grou
ge (yrs)* 0.02
ale gender† 0.02
aucasian
ndication for EPS
Risk stratification
Syncope
Presyncope
Cardiac arrest
istory of MI
ime from MI to study
1 month
1 month
istory PTCA/CABG‡ 0.05
AD (no. of vessels)
1
2
3
HF
istory of hypertension 0.04
istory of diabetes
istory of hypercholesterolemia 0.09
RS duration (ms)
-wave
SVT before EPS
edications
Beta-blocker
ACE-I/ARB
Amiodarone
RI results
Hyperenhancement
Infarct mass (%LV) 0.009
Infarct mass (g) 0.02
Infarct SA (cm2) 0.002
Infarct SA/volume (cm2/ml)
No. of disconnected areas of infarction 0.08
Transmural in 1 region 0.1
Ejection fraction (%)
LV mass (g)
Segmental WMA 0.06
Aneurysm
Infarct location§
Anterior, septum
Inferior
Lateral
Polymorphic VT/VF group older than other groups (p  0.02). †Lower incidence
TCA/CABG in not inducible group versus polymorphic VT/VF group (p 0.05). §
han the total number of patients. p values are listed only if 0.1. Data are presente
ACE-I angiotensin-converting enzyme inhibitor; CHF congestive heart failure;
nfarction; NSVT nonsustained ventricular tachycardia; PTCA percutaneous translu
achycardia; WMA  wall motion abnormality.s positive and negative predictive values in this population. hinally, a sensitivity analysis was performed reclassifying pa-
ients with inducible PVT/VF as either having MVT or being
ot inducible; there was no significant change in the outcomes
f the logistic regression models.
ISCUSSION
ur findings demonstrate that infarct surface area and size,
s measured by MRI, is a better identifier of patients who
Not Inducible
(n  21)
Monomorphic VT
(n  18)
Polymorphic VT/VF
(n  9)
59  3 61  2 71  4
11 (52%) 16 (89%) 8 (88%)
13 (62%) 10 (56%) 7 (78%)
15 (72%) 10 (55%) 6 (67%)
2 (10%) 3 (17%) 1 (11%)
2 (10%) 5 (28%) 1 (11%)
2 (10%) 0 1 (11%)
12 (57%) 13 (72%) 4 (44%)
5 (42%) 2 (15%) 2 (50%)
7 (58%) 11 (85%) 2 (50%)
12 (57%) 14 (78%) 9 (100%)
8 (38%) 1 (5%) 4 (44%)
5 (24%) 5 (28%) 2 (22%)
8 (38%) 12 (67%) 3 (33%)
12 (57%) 14 (78%) 4 (44%)
8 (38%) 11 (61%) 1 (11%)
6 (29%) 5 (28%) 0
8 (38%) 13 (72%) 4 (44%)
110  6 121  5 118  11
11 (52%) 9 (50%) 7 (78%)
13 (62%) 9 (50%) 6 (67%)
16 (76%) 14 (78%) 8 (89%)
16 (76%) 17 (94%) 6 (67%)
4 (19%) 5 (28%) 0
19 (90%) 18 (100%) 8 (89%)
14  3 26  3 20  3
28  5 49  5 36  7
93  14 172  15 115  22
3.5  0.4 3.9  0.3 3.0  0.5
1.3  0.2 1.7  0.1 1.1  0.2
11 (52%) 15 (83%) 7 (78%)
35  3 28  2 34  6
198  14 192  14 178  22
16 (76%) 18 (100%) 7 (78%)
2 (10%) 6 (33%) 2 (22%)
14 (67%) 13 (72%) 6 (67%)
10 (48%) 15 (83%) 5 (56%)
8 (38%) 10 (56%) 4 (44%)
es in the not inducible group than in other groups (p  0.02). ‡Lower incidence of
cts frequently had infarcts in more than one region, resulting in more infarct locations
he mean value  SE or number (%) of subjects.
electrophysiologic study; HTN hypertension; LV left ventricle; MI myocardial
coronary angioplasty; SA surface area; VF ventricular fibrillation; VT ventricularps)
of mal
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easured by LVEF, maximum creatine kinase, and the
umber of fixed thallium defects, is related to induction of
entricular arrhythmias (1,27–31). Based on autopsy find-
ngs, Bolick et al. (4) reported that patients with clinical VT
fter myocardial infarction had larger infarcts than those
ithout. Recently, extensive scar tissue detected by
echnetium-99m tetrofosmin scintigraphy was reported as
igure 1. Plot of infarct size characteristics versus left ventricular ejection
raction. The regression lines are based on data from all 48 subjects.
owever, individual data points are shown only for patients with inducible
onomorphic ventricular tachycardia (circles) and those without inducible
entricular arrhythmias (squares).
igure 2. The receiver-operating characteristic curves for infarct surfacep
rea and ejection fraction as predictors of inducibility of monomorphic
entricular tachycardia.n independent predictor of death or recurrent ventricular
rrhythmias in survivors of aborted sudden death (32).
ecause improvements in ceMRI have allowed delineation
f infarct regions with high precision (12–17), we were able
o demonstrate that infarct size, measured in vivo, is an
mportant predictor of induction of MVT during EPS.
The LVEF in this study and others (8–11) is inversely
elated to infarct size, although the strength of this relation-
hip may be poor. Many factors affect LVEF aside from
nfarct size, such as preload, afterload, autonomic factors,
edications, and post-infarction remodeling (33). Many of
hese may also influence the pathogenesis of ventricular
achyarrhythmias by affecting the substrate or by serving as
riggers or modulating factors. As inducibility of VT during
PS evaluates for the presence of a fixed substrate for VT,
t is not surprising that the factor most closely linked to the
natomic substrate—infarct size (surface area)—is a better
iscriminator of inducible VT than LVEF, which is affected
y so many other variables. Interestingly, a recent study (32)
ound that extensive scar tissue had a higher hazard ratio for
ecurrent events than LVEF (2.4 vs. 2.0), although the
efinition of extensive scar tissue was not clearly stated.
The clinical significance of inducible PVT/VF has been
he subject of controversy. Induction of PVT/VF may be a
onspecific response to aggressive stimulation, as it may be
bserved frequently in patients with normal hearts (21,24).
et, the clinical significance of these arrhythmias might differ
epending on the presence and severity of heart disease. These
rrhythmias are inducible in a substantial percentage of pa-
ients who have survived cardiac arrest (25,34,35). Further-
ore, in some patients, after treatment with anti-arrhythmic
gents, MVT can be induced (36,37); it is therefore plausible
hat these patients have a fixed substrate for ventricular ar-
hythmias that, in the absence of anti-arrhythmic drugs, is
able 2. Sensitivity, Specificity, Positive Predictive Value, and
egative Predictive Value of Various Cut-Off Values for the
ndicated Parameters
Sensitivity Specificity
Positive
Predictive
Value
Negative
Predictive
Value
jection fraction
30% 56% 62% 56% 62%
35% 72% 48% 54% 67%
40% 89% 38% 55% 80%
nfarct surface area
200 cm2 33% 95% 86% 63%
150 cm2 61% 81% 73% 71%
100 cm2 89% 57% 64% 86%
nfarct mass
25% 44% 86% 73% 64%
20% 56% 76% 67% 67%
15% 89% 48% 59% 83%
nfarct mass
35 g 78% 81% 78% 81%
30 g 83% 62% 65% 81%
25 g 94% 43% 59% 90%olymorphic. Further studies are warranted to delineate
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he induction of PVT/VF is clinically significant.
The present findings demonstrate that characterization of
nfarct size is a better predictor than LVEF for inducibility
f VT. Although inducibility of VT is not the ideal risk
tratifier for prediction of sudden death, LVEF is a known
trong predictor. If the role of LVEF as a predictor of
udden death is a surrogate marker for infarct size, then it is
ossible that measurement of infarct size by ceMRI may be
better predictor of sudden death than LVEF. Further
tudies comparing the roles of LVEF and infarct size for
rediction of clinical events are warranted.
eprint requests and correspondence: Dr. Jeffrey J. Goldberger,
einberg School of Medicine, Northwestern University, Divi-
ion of Cardiac Electrophysiology, 251 East Huron, Feinberg
avilion 8-542, Chicago, Illinois 60611. E-mail: j-goldberger@
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